MGRXMangoceuticals Inc. Common Stock
0.4220USD+0.93%Mkt Cap: 9.10M $P/E: —3d ago
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products …
Industry Peers
Health Information ServicesKey Statistics
Company
Market Cap9.10M $
Enterprise Value8.37M $
Revenue (TTM)315.23K $
Gross Profit250.39K $
Net Income (TTM)-20.64M $
Revenue/Share0.0210 USD
Last Price0.4220 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorTechnology
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.68
EV/Revenue26.54
P/S26.39
P/B0.55
EPS (TTM)-0.94
EPS (Forward)—
52W Range
0.162010% of range2.750
52W High2.750 USD
52W Low0.1620 USD
Profitability
Gross Margin54.91%
Oper. Margin-1502.45%
EBITDA Margin0.00%
Profit Margin-4526.76%
ROE-135.80%
ROA-128.30%
Growth
Revenue Growth-59.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.85M $
CapEx (TTM)—
FCF Margin428.80%
FCF Yield14.85%
Net Debt50.52K $
Net Debt/EBITDA-0.00
Balance Sheet
Debt/Equity0.02
Current Ratio0.18
Quick Ratio0.16
Book Value/Sh0.6950 USD
Cash/Share0.0110 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateOct 16, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.21.57M
Float16.87M
Insiders7.99%
Institutions5.62%
Short Interest
Short Ratio0.1d
Short % Float12.19%
Short % Out.10.96%
Shares Short1.88M
Short (prev mo.)385.97K
Technical
SMA 500.4323 (-2.4%)
SMA 2000.6005 (-29.7%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)21.50M
Avg Vol (10d)6.55M
Technical Indicators
RSI (14)45.3
MACD0.0112
MACD Signal0.0244
MACD Hist.-0.0132
BB Upper0.6471 USD
BB Middle0.5065 USD
BB Lower0.3658 USD
BB Width55.54%
ATR (14)0.1103 USD
Vol Ratio (20d)0.03x